TRiCares Announces First Topaz Implantations in US Early Feasibility Study Paris, France and Munich, Germany, January 09, 2025 – TRiCares SAS (“TRiCares”), a company pioneering a minimally-invasive tricuspid valve that flexes with every heartbeat, announces that the first...

TRiCares Announces First Topaz Implantation in EU Pivotal Study TRiCares Announces First Topaz Implantation in EU Pivotal StudyParis, France and Munich, Germany, September 24, 2024 – TRiCares SAS (“TRiCares”), a company pioneering a minimally-invasive tricuspid...

TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones Paris, France and Munich, Germany, July 25, 2024 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field...

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker Paris, France and Munich, Germany, December 21, 2023 –...